Gene · 5927
Papers1,684
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,684
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic-related transcriptional reprogramming elucidated by identification and validation of a novel reference gene combination for RT-qPCR studies in porcine oocytes of contrasting quality. | Mol Biol Rep | 2024 | 38411699 | PubTator, text mining | PubMed |
| The Dynamics of Histone Modifications during Mammalian Zygotic Genome Activation. | Int J Mol Sci | 2024 | 38338738 | PubTator, text mining | PubMed |
| Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. | Int J Mol Sci | 2024 | 38279330 | PubTator, text mining | PubMed |
| An update of predictive biomarkers related to WEE1 inhibition in cancer therapy. | J Cancer Res Clin Oncol | 2024 | 38231277 | PubTator, text mining | PubMed |
| KDM5B predicts temozolomide-resistant subclones in glioblastoma. | iScience | 2024 | 38174322 | PubTator, text mining | PubMed |
| The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target. | BMC Cancer | 2024 | 38166703 | PubTator, text mining | PubMed |
| Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review). | Oncol Rep | 2024 | 38131215 | PubTator, text mining | PubMed |
| Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. | Noncoding RNA Res | 2024 | 38075202 | PubTator, text mining | PubMed |
| Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA. | Redox Biol | 2024 | 38042059 | PubTator, text mining | PubMed |
| Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma. | J Pathol Clin Res | 2024 | 37974379 | PubTator, text mining | PubMed |
| The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2024 | 37692513 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis. | Cancer Res Treat | 2024 | 37591783 | PubTator, text mining | PubMed |
| A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. | Cancer Res Treat | 2024 | 37475136 | PubTator, text mining | PubMed |
| NUP98 rearrangements in AML: molecular mechanisms and clinical implications. | Onco (Basel) | 2023 | 42164049 | PubTator, text mining | PubMed |
| Metastasis and cancer associated fibroblasts: taking it up a NOTCH. | Front Cell Dev Biol | 2023 | 38269089 | PubTator, text mining | PubMed |
| Noval advance of histone modification in inflammatory skin diseases and related treatment methods. | Front Immunol | 2023 | 38235133 | PubTator, text mining | PubMed |
| Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning. | Brief Bioinform | 2023 | 38197309 | PubTator, text mining | PubMed |
| A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer. | J Gastrointest Oncol | 2023 | 38196539 | PubTator, text mining | PubMed |
| The Construction and Validation of a Novel Ferroptosis-Related Gene Signature in Parkinson's Disease. | Int J Mol Sci | 2023 | 38139032 | PubTator, text mining | PubMed |
| Mesenchymal stem cells and dental implant osseointegration during aging: from mechanisms to therapy. | Stem Cell Res Ther | 2023 | 38124153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5927/papers?page=6